By Christy Santhosh Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up ...

Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. New research is raising the prospect of ...

Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...

Formation Bio and Jiangsu Chia Tai Feng Hai Pharmaceutical Co., LTD. (CTFH) today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to FHND5032, an oral, ...

Initial results as promising as those in lupus and other non-cancer diseases driven by B c ...

As part of the deal, Repertoire Immune Medicines will develop up to three drug candidates that target the drivers of certain autoimmune diseases.

The ubiquitous Epstein-Barr virus is increasingly being linked to conditions like multiple sclerosis and lupus. But why do ...

What if the very internal system that is meant to protect us, our body, our organs, starts to turn against us? That's right! With the sharp rise in Autoimmune diseases in the world, launching attacks ...

Add Yahoo as a preferred source to see more of our stories on Google. Early discussions and proactive planning for pregnancy are critically important for those with autoimmune diseases. d3sign/Moment ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed symptom of autoimmune diseases? Hair loss. Your immune system is meant to keep ...

A relatively new class of autoimmune diseases that affect the brain is making psychiatrists rethink some diagnoses.

Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the Massachusetts-based ...